nach oben

European Journal of Epidemiology

Erschienen in:

22.07.2015 | LETTER TO THE EDITOR

A different interpretation of the efficacy of lung cancer screening in the PLCO trial

verfasst von: Motoyasu Sagawa, Tomio Nakayama, Tomotaka Sobue, The JECS Study Group

Erschienen in: European Journal of Epidemiology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Excerpt

In 2011, the results of lung cancer screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO trial) were reported [1]. Although the report was very important, it was surprising that there have not been different interpretations from the results of PLCO trial thus far. The conclusion of the PLCO trial was agreeable, in which annual chest radiographic screening for 3–4 years did not show any effect on the cumulative lung cancer mortality during a 13-year follow-up period [1]. However, the report ignored important points that should be carefully discussed. …

Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;. doi:10.1001/jama.2011.1591.PubMed

Miettinen OS, Henschke CI, Yankelevitz DF. Mammographic screening: no reliable supporting evidence? Lancet. 2002;359:404–6.CrossRefPubMed

Chien CR, Chen TH. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer. 2008;122:2594–9.CrossRefPubMed

Wu D, Erwin D, Rosner GL. Sojourn time and lead time projection in lung cancer screening. Lung Cancer. 2011;72:322–6.CrossRefPubMed

Sagawa M, Nakayama T, Tsukada H, et al. The efficacy of lung cancer screening conducted in 1990s: 4 case–control studies in Japan. Lung Cancer. 2003;41:29–36.CrossRefPubMed

Titel: A different interpretation of the efficacy of lung cancer screening in the PLCO trial
verfasst von: Motoyasu Sagawa
Tomio Nakayama
Tomotaka Sobue
The JECS Study Group
Publikationsdatum: 22.07.2015
Verlag: Springer Netherlands
Erschienen in: European Journal of Epidemiology / Ausgabe 2/2016
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-015-0070-1

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

A different interpretation of the efficacy of lung cancer screening in the PLCO trial

Excerpt

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2016

Clinical findings and diagnosis in genetic prion diseases in Germany

Ophthalmic epidemiology in Europe: the “European Eye Epidemiology” (E3) consortium

Registers of the Swedish total population and their use in medical research

Personality traits and the risk for Parkinson disease: a prospective study

Trajectories of self-rated health in the last 15 years of life by cause of death

Increased attrition of leukocyte telomere length in young adults is associated with poorer cognitive function in midlife